LECM
ENFN

Lead Edge Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Lead Edge Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,409,967
Closed -$26.9M – 11
2025
Q1 		$26.9M Hold
2,409,967
– – 8.16% 6
2024
Q4 		$24.8M Hold
2,409,967
– – 8.4% 6
2024
Q3 		$22.9M Buy
2,409,967
+674,416
+39% +$5.82M 6.62% 6
2024
Q2 		$14.8M Buy
1,735,551
+884,584
+104% +$8.09M 4.72% 8
2024
Q1 		$7.87M Buy
+850,967
New +$7.49M 2.42% 9

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lead Edge Capital Management's ENFN Position: Q2 2025 in Review

Lead Edge Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 2,409,967 shares — an estimated $26.9M sold.

Lead Edge Capital Management first reported a position in ENFN in Q1 2024 and held it in 5 quarters. The position peaked at $26.9M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Lead Edge Capital Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Lead Edge Capital Management sold 2,409,967 Enfusion, Inc. shares in Q2 2025, an estimated $26.9M.
  • Lead Edge Capital Management first reported a position in Enfusion, Inc. in Q1 2024 and held it in 5 quarters.
  • Lead Edge Capital Management's Enfusion, Inc. position peaked at $26.9M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Lead Edge Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.